OCWP
BSX icon

Owl Creek Wealth Partners’s Boston Scientific BSX Stock Holding History

Owl Creek Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.8K Buy
1,964
+274
+16% +$14.9K 0.02% 234
2026
Q1 		$106K Buy
+1,690
New +$135K 0.04% 170

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Owl Creek Wealth Partners's BSX Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its Boston Scientific (BSX) stake by 16% in Q2 2026, buying an estimated $14.9K and bringing the position to 1,964 shares worth $83.8K. The position accounts for 0.02% of the portfolio, ranked #234.

Owl Creek Wealth Partners first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $106K in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Owl Creek Wealth Partners held 1,964 shares of Boston Scientific worth $83.8K as of Q2 2026.
  • Owl Creek Wealth Partners bought 274 Boston Scientific shares in Q2 2026, an estimated $14.9K.
  • Boston Scientific made up 0.02% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #234 holding.
  • Owl Creek Wealth Partners first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Boston Scientific position peaked at $106K in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.